Cornell Translational Behavioral Science Research Consortium: Hypertension Qualitative Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00227175

Enrollment

Registered

2005-09-27

Start date

2003-04-30

Completion date

2003-09-30

Last updated

2008-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

African American, Hypertension, Medication adherence, Risk reduction

Brief summary

To explore the meaning, causes and treatment of hypertension in eligible patients. In addition the cultural, social, and psychological factors that either facilitate or serve, as barriers to behavioral change will be illuminated in this patient population.

Detailed description

1. The first goal is to explore the meaning, causes and treatment of hypertension in eligible patients. In addition the cultural, social, and psychological factors that either facilitate or serve, as barriers to behavioral change will be illuminated in this patient population. Through a series of open-ended questions we will explore and build a better understanding of how hypertensive African American patients view their illness and the difficulties they have in taking their antihypertensive medications as prescribed. 2. The second goal of the qualitative phase is to use the responses obtained to inform how we should operationalize and tailor the positive affect induction and self-affirmation intervention methods in hypertensive African American patients.

Interventions

BEHAVIORALSemi-structured, open ended interview

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

1. Patients must be self-identified as African-Americans. 2. All patients must be aged 18 years and older. 3. All patients must be diagnosed as having hypertension: For this project, hypertension will be defined according to the widely accepted criteria of the 6th Joint National Committee (JNC VI) Guidelines on Prevention, Detection, Evaluation and Treatment of Hypertension, which is a systolic blood pressure \> 140 mm hg or a diastolic blood pressure \> 90 mm hg or if participants are taking any prescribed antihypertensive medication. 4. Patients must be able to provide informed consent in English.

Exclusion criteria

1. Patients who refuse to participate 2. Patients who are unable to provide informed consent.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 27, 2026